Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
index medicus (23) 23
male (21) 21
middle aged (20) 20
female (19) 19
abridged index medicus (18) 18
cardiac & cardiovascular systems (16) 16
aged (15) 15
secondary prevention (13) 13
treatment outcome (13) 13
myocardial infarction (12) 12
myocardial infarction - drug therapy (12) 12
double-blind method (11) 11
heart attacks (11) 11
heart attack (9) 9
prevention (9) 9
stroke (9) 9
care and treatment (8) 8
medicine, general & internal (8) 8
patients (8) 8
risk factors (8) 8
acute coronary syndromes (7) 7
analysis (7) 7
cardiovascular diseases (7) 7
clopidogrel (7) 7
dosage and administration (7) 7
hemorrhage - chemically induced (7) 7
kaplan-meier estimate (7) 7
risk (7) 7
stroke - prevention & control (7) 7
ticagrelor (7) 7
atherosclerosis (6) 6
cardiovascular disease (6) 6
cardiovascular diseases - mortality (6) 6
myocardial infarction - diagnosis (6) 6
myocardial infarction - mortality (6) 6
peripheral vascular disease (6) 6
pyridines - therapeutic use (6) 6
safety (6) 6
acute coronary syndrome (5) 5
adenosine - analogs & derivatives (5) 5
aspirin (5) 5
cardiology (5) 5
cardiovascular diseases - prevention & control (5) 5
cerebral infarction (5) 5
drug administration schedule (5) 5
drug therapy (5) 5
follow-up studies (5) 5
lactones - therapeutic use (5) 5
mortality (5) 5
myocardial infarction - prevention & control (5) 5
platelet aggregation inhibitors - therapeutic use (5) 5
transluminal angioplasty (5) 5
adenosine - administration & dosage (4) 4
antiplatelet therapy (4) 4
bleeding (4) 4
cardiac patients (4) 4
coronary heart disease (4) 4
coronary vessels (4) 4
diabetes mellitus (4) 4
electrocardiography (4) 4
ischemia (4) 4
myocardial infarction - therapy (4) 4
platelet aggregation inhibitors - adverse effects (4) 4
pyridines - adverse effects (4) 4
secondary prevention - methods (4) 4
thrombolytic therapy (4) 4
time factors (4) 4
trial (4) 4
usage (4) 4
acute coronary syndrome - drug therapy (3) 3
adenosine - adverse effects (3) 3
adult (3) 3
angioplasty (3) 3
arteriosclerosis (3) 3
cardiovascular outcomes (3) 3
cholesterol (3) 3
clinical outcomes (3) 3
clinical trials (3) 3
coronary angiography (3) 3
death (3) 3
diabetes (3) 3
disease prevention (3) 3
health aspects (3) 3
health risk assessment (3) 3
heart-disease (3) 3
human health and pathology (3) 3
lactones - adverse effects (3) 3
life sciences (3) 3
myocardial infarction - epidemiology (3) 3
myocardial infarction - metabolism (3) 3
myocardial ischemia - prevention & control (3) 3
peripheral arterial disease (3) 3
peripheral arterial disease - drug therapy (3) 3
prediction (3) 3
purinergic p2y receptor antagonists - administration & dosage (3) 3
randomization (3) 3
receptor, par-1 - antagonists & inhibitors (3) 3
recurrence (3) 3
vorapaxar (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
by Cannon, Christopher P and Blazing, Michael A and Giugliano, Robert P and McCagg, Amy and White, Jennifer A and Theroux, Pierre and Darius, Harald and Lewis, Basil S and Ophuis, Ton Oude and Jukema, J. Wouter and De Ferrari, Gaetano M and Ruzyllo, Witold and De Lucca, Paul and Im, KyungAh and Bohula, Erin A and Reist, Craig and Wiviott, Stephen D and Tershakovec, Andrew M and Musliner, Thomas A and Braunwald, Eugene and Califf, Robert M and IMPROVW-IT Investigators and IMPROVE-IT Investigators
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
by Hohnloser, Stefan H and Steg, Philippe Gabriel and Oldgren, Jonas and Nickenig, Georg and Kiss, Robert G and Ongen, Zeki and Navarro Estrada, Jose L and Oude Ophuis, Ton and Lip, Gregory Y.H and Nordaby, Matias and Kleine, Eva and ten Berg, Jurrien M and Bhatt, Deepak L and Cannon, Christopher P and RE-DUAL PCI Steering Comm
JACC: Cardiovascular Interventions, ISSN 1936-8798, 08/2019, Volume 12, Issue 16, pp. 1553 - 1561
The study sought to evaluate the effect of dabigatran dual therapy versus warfarin triple therapy across categories of renal function in the RE-DUAL PCI... 
warfarin triple therapy | renal function | atrial fibrillation | dabigatran dual therapy | percutaneous coronary intervention | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | PREVENTION | TIME | ANTICOAGULATION | STROKE | TRIAL | WARFARIN | RANGE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
by Bonaca, Marc P and Bhatt, Deepak L and Cohen, Marc and Steg, Philippe Gabriel and Storey, Robert F and Jensen, Eva C and Magnani, Giulia and Bansilal, Sameer and Fish, M. Polly and Im, Kyungah and Bengtsson, Olof and Ophuis, Ton Oude and Budaj, Andrzej and Theroux, Pierre and Ruda, Mikhail and Hamm, Christian and Goto, Shinya and Spinar, Jindrich and Nicolau, José Carlos and Kiss, Robert G and Murphy, Sabina A and Wiviott, Stephen D and Held, Peter and Braunwald, Eugene and Sabatine, Marc S and PEGASUS-TIMI 54 Steering Comm and PEGASUS-TIMI 54 Steering Committee and Investigators
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights